( July 30, 2025, 12:31 PM EDT) -- TRENTON, N.J. — The New Jersey Supreme Court has asked for comments on two applications to create separate multicounty litigation (MCL) designations for state court cases alleging that permanent vision loss and gastrointestinal injuries were caused by the use of glucagon-like peptide-I receptor agonist (GLP-1 RA) medications....